openPR Logo
Press release

Ocular Drug Delivery Market Size, Share, Growth, Trends And Forecast 2024-2033

Ocular Drug Delivery Market

Ocular Drug Delivery Market

The Business Research Company recently released a comprehensive report on the Global Ocular Drug Delivery Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=11901&type=smp

According to The Business Research Company's, The ocular drug delivery market size has grown strongly in recent years. It will grow from $17.39 billion in 2023 to $18.64 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rise in ocular diseases, aging population trends, advancements in pharmaceutical formulations, clinical advancements in ophthalmology, prevalence of diabetes-related eye conditions..

The ocular drug delivery market size is expected to see strong growth in the next few years. It will grow to $24.98 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rising incidence of age-related eye diseases, focus on personalized medicine in ophthalmology, increased investment in ophthalmic research, demand for prolonged drug release, global initiatives for eye health.. Major trends in the forecast period include integration of smart drug delivery devices, personalized medicine in ocular drug formulations, development of topical ophthalmic therapies, collaborations for cross-industry innovations..

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/ocular-drug-delivery-global-market-report

Market Drivers and Trends:

An increase in the prevalence of eye disorders is expected to propel the growth of the ocular drug delivery market going forward. Eye disorders refer to a wide range of conditions that affect the eyes, vision, or the structures surrounding the eyes. Ocular drug delivery allocates medications directly to the target site, providing greater drug concentrations at the targeted area, optimizing therapeutic efficacy while avoiding systemic adverse effects, and improving eye disorders. For instance, in March 2023, according to the World Health Organization, a Switzerland-based United Nations agency, globally, 2.2 billion people will have a near- or far-sighted impairment. According to estimates, cataracts (94 million) and uncorrected refractive problems (88.4 million) are the main causes of visual loss or impaired vision. In addition, glaucoma (7.7 million cases), corneal opacities (4.2 million cases), diabetic retinopathy (3.9 million cases), and trachoma (2 million cases) are the other common causes of vision loss. Therefore, the increase in the prevalence of eye disorders is driving the growth of the ocular drug delivery market.

Product innovation is a key trend gaining popularity in the ocular drug delivery market. Companies operating in the ocular drug delivery market are focused on developing new product innovations to sustain their position in the market. For instance, in March 2023, Alcon AG, a Swiss pharmaceutical and medical device firm focusing on eye care products, launched TOTAL30 for astigmatism and SYSTANE HYDRATION for dry eye and ocular health. TOTAL30 is the debut and only Toric lens to combine water Gradient and Celligent Technology, allowing the lens that mimics the structure of the ocular surface and provides superior performance in areas like comfort, stability, and visual acuity. SYSTANE HYDRATION PF is an ocular health eye drop that uses HydroBoost technology to restore moisture, prevent irritation, and give relief from dry eye symptoms.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Akorn Inc., Valeant Pharmaceuticals International Inc., Aerie Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., Ophthotech Corporation, Acucela Inc., Graybug Vision Inc., Amakem NV, Kala Pharmaceuticals Inc., Icon Bioscience Inc., Clearside Biomedical Inc., Aerpio Therapeutics Inc., Senju Pharmaceutical Co. Ltd., Shire plc, Spark Therapeutics Inc., Sucampo Pharmaceuticals Inc., Carl Zeiss Meditec AG, EyeGate Pharmaceuticals Inc.

Ocular Drug Delivery Market 2024 Key Insights:

• The ocular drug delivery market size is expected to see strong growth in the next few years. It will grow to $24.98 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%.
• Rising Prevalence Of Eye Disorders Boosts Ocular Drug Delivery Market
• Pioneering Product Innovations In The Ocular Drug Delivery Market
• North America was the largest region in the ocular drug delivery market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=11901&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ocular Drug Delivery Market Size, Share, Growth, Trends And Forecast 2024-2033 here

News-ID: 3769952 • Views:

More Releases from The Business Research Company

Advanced Diagnostics And Treatments Drive Demand For PTA Balloon Catheters: A Key Catalyst Accelerating PTA Balloon Catheter Market Growth in 2025
Advanced Diagnostics And Treatments Drive Demand For PTA Balloon Catheters: A Ke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. PTA Balloon Catheter Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the recent past, the market size for pta balloon catheter has seen substantial growth. The projections reveal that the growth scale will go up from $2.33 billion in 2024 to $2.56 billion in
Soaring Demand Set to Propel Nuclear Medicine Diagnostics Market to $12.38 Billion by 2029
Soaring Demand Set to Propel Nuclear Medicine Diagnostics Market to $12.38 Billi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Nuclear Medicine Diagnostics Market Through 2025? In recent years, the nuclear medicine diagnostics market has seen a quick expansion. The market's size will increase from $7.16 billion in 2024 to $7.88 billion in 2025 at a compound annual growth rate (CAGR) of
Rising Incidence Of Infectious Diseases Fuels Growth In Molecular Diagnostic Devices Market Driving Market Acceleration in the Molecular Diagnostics Devices And Equipment Industry, 2025
Rising Incidence Of Infectious Diseases Fuels Growth In Molecular Diagnostic Dev …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Molecular Diagnostics Devices And Equipment Market Size By 2025? In recent times, the molecular diagnostics devices and equipment market has seen significant expansion. The market is set to rise from $24.4 billion in 2024 to $27.23 billion in 2025, exhibiting a compound annual growth rate
Driving Masks (N95 Respirators And Other Surgical Masks) Market Growth in 2025: The Role of Exponential Growth In The N95 Respirators And Surgical Masks Market Amidst The COVID-19 Pandemic
Driving Masks (N95 Respirators And Other Surgical Masks) Market Growth in 2025: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Masks (N95 Respirators And Other Surgical Masks) Market Size Growth Forecast: What to Expect by 2025? The market for masks, including n95 respirators and surgical masks, has seen a significant plunge in its size in the last few years. The market worth is projected to dip from $12.88 billion

All 5 Releases


More Releases for Ocular

How the Ocular Pain Market Is Growing in 2025 | What's New Treatments Are Coming …
According to the IMARC Group, the ocular pain market is expected to exhibit a CAGR of 7.66% during 2025-2035. This can be attributed to the growing use of services in teleophthalmology, which facilitates remote consultations and enhances patient adherence. Ocular pain is the discomfort or distress experienced within or around the eye. The ocular pain market is experiencing significant growth driven by multiple factors. Primarily, the increasing prevalence of conditions such
Key Influencer in the Ocular Implants Market 2025: Growing Geriatric Population …
What market dynamics are playing a key role in accelerating the growth of the ocular implants market? The growth of the ocular implants market is foreseen to be driven by the global increase in the geriatric population. The term 'geriatric population' is specifically used to refer to individuals aged 65 years or above. Ocular implants offer a solution to age-specific eye ailments prevalent among the elderly, such as cataracts, glaucoma, and
Neuropathic Ocular Pain Market Is Booming Worldwide 2025-2032 | OKYO Pharma, Lim …
Latest Report, titled "Neuropathic Ocular Pain Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Neuropathic Ocular Pain market has been
Neuropathic Ocular Pain Market Detailed In New Research Report 2024 |OKYO Pharma …
A recent report from Coherent Market Insight titled "Neuropathic Ocular Pain Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2031" presents a thorough examination of the industry landscape, offering insights into market analysis and trends. Alongside competitor and regional analysis, the report delves into contemporary advancements within the market. Global Neuropathic Ocular Pain market is estimated to be valued at US$ 197.1 million in 2023 and is expected to
Ocular Neuropathic Pain Market to witness Robust Expansion by 2031 - OKYO Pharma …
Ocular neuropathic pain (ONP) is chronic eye pain caused by nerve damage or dysfunction. It can result from various conditions, such as corneal nerve injury, ocular surgeries, infections, or systemic diseases like diabetes. Patients experience persistent, burning, or stabbing eye pain, often without visible signs of inflammation. Diagnosis involves detailed patient history, clinical examination, and sometimes specialized tests. Treatment focuses on managing pain and may include topical or systemic medications,
Ocular Implant Market - Redefining Ophthalmic Solutions: Choose Ocular Implants …
Newark, New Castle, USA: The "Ocular Implant Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Ocular Implant Market: https://www.growthplusreports.com/report/ocular-implant-market/7864 This latest report researches the industry structure, sales, revenue,